NIPH Clinical Trials Search

JRCT ID: jRCTs032210224

Registered date:06/08/2021

Verification study of the new peripheral intravenous catheter

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedDiseases which are needed administration of stimulating drugs
Date of first enrollment24/08/2021
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)Randomization of catheterization using new unapproved peripheral intravenous catheter at the upper arm vein with using a short peripheral intravenous catheter at the forearm vein


Primary OutcomeThe incidence rate of catheter failures (%)
Secondary Outcome1) The incidence rate of catheter failures per 1000 days 2) Presence or absence of a thrombus in the vessel and a subcutaneous edema 3) Signs and symptoms such as redness, swelling, induration and occulusion 4) Subjective evaluation of catheter placement

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Include criteriaPatients must satisfy the followings; . 1) Patients are scheduled to administrate stimulant drugs using peripheral intravenous catheter. 2) Over 19 years, regardless of gender 3) Patients are scheduled to continuous infusion therapy over 24 hours 4) Patients give us their written consent for the study 5) The first catheterization at this hospitalization
Exclude criteriaThe following patients must be excluded. 1) Patients are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint 2) Having skin disorders at the puncture site 3) Having peripheral neuropathy 4) Having a history of vasovagal reflex due to puncture 5) Having a history of thrombosis 6) With end-stage renal disease (stage 2 or higher) 7) Having abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drugs) 8) Patient is planned of highly invasive tests (endoscopy, bronchoscopy) 9) Participation of this study is judged inappropriate for patient by physician

Related Information


Public contact
Name Murayama Ryoko
Address 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi Aichi Japan 470-1192
Telephone +81-562-93-9446
Affiliation Fujita Health University
Scientific contact
Name Kurokawa Mineo
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo Tokyo Japan 113-8655
Telephone +81-3-3815-5411
Affiliation The University of Tokyo Hospital